<DOC>
	<DOCNO>NCT00639951</DOCNO>
	<brief_summary>The purpose study compare whether total dose give front single dose effective safe dose give fraction dose . Evaluate Utility Dry Tube Test Evaluating Correlation Coagulation Test Results ( fibrinogen , platelet , INR , PT PTT ) . Explore Evolution Serum Markers ( CK , DHL , metalloproteinase ) , Amount Venom Antivenom Levels Progression Local Lesions .</brief_summary>
	<brief_title>Study Evaluate Efficacy Two Treatment Schemes With Antivipmyn ® Treatment Snake Bite Envenomation</brief_title>
	<detailed_description>Snake bite Envenomation Public Health Problem especially tropical subtropical country . The WHO estimate 40 000 annual death world cause . In México Ministry Health estimate 3 882 case 2005 , age 15-44 affected . There official number mortality , although thought case death , related delay treatment . There broad variety clinical presentation depend many factor specie , snake bite variability patient condition . Proteolytic action venom produce amine vasoactive peptide bradykinin , histamine serotonin cause capillary lesion anticoagulant effect . Coagulopathy one important systemic consequence . The Dry Tube Test propose indirect test evaluate coagulopathy related pathology .</detailed_description>
	<mesh_term>Snake Bites</mesh_term>
	<criteria>Men woman 6 65 year age Presenting emergency treatment snake bite Requiring treatment antivenom Informed consent document read sign patient ( parent/legal guardian ) Participation within last month clinical trial Arrival Hospital within 24 hour snake bite Allergy horse serum Underlying medical condition significantly alter coagulation ( oral anticoagulant , vitamin K deficiency , hepatic disease ) Use AINE 48 hour previously Use antivenom 2 week previously Pregnancy breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Snake Bite</keyword>
	<keyword>Antivenin Treatment</keyword>
</DOC>